Expert Interviews

Effective Breast Cancer Prevention Requires A Primary Care Advocate, Expert Says
October 17, 2024

After a false positive breast cancer screening result, women may be reluctant to participate in future screening, a topic that could benefit from the primary care touch.

Understanding the Obesity-Hypertension Connection: A Clinician Discussion
October 16, 2024

Caissa Troutman, MD, provides an overview of the connection between obesity and hypertension.

False Positive Breast Cancer Screening Linked with Greater Risk of Later Diagnosis
October 16, 2024

Even after adjusting for breast density, studies reveal a significantly greater risk for a cancer diagnosis within 2 decades. A UC Davis expert offers details.

How Likely is a False Positive Breast Cancer Screening Result? Veteran Researcher Explains
October 15, 2024

A false positive finding on a screening mammogram is fairly common, according to UC Davis biostatistician Diana Miglioretti, PhD. Here's why.

After a False Positive Result, Screening Mammography May Not be a Priority for Some Women
October 14, 2024

The group of women least likely to return for a regular preventive screening mammogram after a false positive result surprised this primary investigator.

Researcher Explains How Women Respond to a False Positive Breast Cancer Screening Result
October 11, 2024

After a false positive outcome on screening mammography, a short interval call back for repeat imaging was a significant deterrent to future screening.

The Potential Harms of Breast Cancer Screening Need to be Explored and this Biostatistician is All In
October 10, 2024

The most common harm associated with breast cancer screening is a false positive finding; this UC Davis expert wanted to know more about how women respond.

Menopausal VMS Education in Primary Care: Build Trust First, Says One Clinician
October 08, 2024

Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.

Menopausal Vasomotor Symptoms: Clinician and Patients Both Need Education, Expert Says
October 07, 2024

Less than 15% of women in menopause receive treatment for VMS, suggesting a need a for more education and awareness, according to JoAnn Pinkerton, MD.

Switching from HRT to Non-HRT: Safety Considerations for Menopausal Women
October 04, 2024

An expert discussion with JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program of elinzanetant for moderate-to-severe VMS.